Latin American Institute of Biotechnology MECHNIKOV, S.A. cares about the quality, effectiveness and safety of the products it puts into circulation.

Institute MECHNIKOV S.A. has a system for accounting for spontaneous reports from health system workers, patients, distributors, and is actively monitoring information on the development of adverse reactions or lack of efficacy.

If you become aware of adverse events, which occurred after the application of products manufactured by  MECHNIKOV, S.A. Institute, we ask that you inform us in any way you wish:

Pharmacovigilance (Download form)

Reports on the safety monitoring of the pharmaceutical product "Fractionated inactivated influenza vaccine"